What is it about?

The article discusses the role of perirenal fat thickness in the pathophysiology of chronic kidney disease in patients with diabetes. The study confirms the impact of PRF on adverse cardiovascular risk features and CKD progression. However, the study has some limitations and the findings should be considered suggestive rather than conclusive. Early detection and treatment of PRF may contribute to reducing the global burden of these diseases. [Some of the content on this page has been created by AI]

Featured Image

Why is it important?

This research is important because it sheds light on the role of perirenal fat (PRF) thickness in the pathophysiology of chronic kidney disease (CKD) in patients with diabetes. The study confirms the key impact of PRF on adverse cardiovascular risk features and CKD progression, which is crucial for early detection and treatment to reduce the global burden of these diseases. Key Takeaways: 1. Perirenal fat (PRF) thickness is a novel independent risk factor for CKD progression and is associated with cardiorenal dysfunction. 2. The study confirms the key impact of PRF on adverse cardiovascular risk features and CKD progression. 3. Early detection and treatment of PRF may contribute to reducing the global burden of chronic kidney disease and related diseases.

Read the Original

This page is a summary of: Perirenal Fat and Chronic Kidney Disease in Patients With Diabetes, Diabetes, September 2021, American Diabetes Association,
DOI: 10.2337/dbi21-0032.
You can read the full text:

Read

Contributors

The following have contributed to this page